Quidel Molecular Programs extend the continuum of diagnostic choices from rapid immunoassays to confirmatory nucleic acid testing. Quidel has three development programs which may appeal to those labs just starting out in molecular, to experts that are looking for consistent, high quality results.
For more information, CLICK HERE.
Marketed under the leading brand name of QuickVue, Quidel's portfolio of products currently includes tests that aid in the diagnosis of several disease or condition states, including influenza, RSV, fecal occult blood, Strep A, pregnancy, bacterial vaginosis, infectious mononucleosis, H. pylori, and Chlamydia.
The Quidel Specialty Products Group identifies, develops, manufactures and markets unique diagnostic and research assays and reagents with applications in oncology, bone health and inflammatory diseases. Our kits and reagents are marketed worldwide under the MicroVue brand.